Biosidus Revenue and Competitors
Estimated Revenue & Valuation
- Biosidus's estimated annual revenue is currently $103.3M per year.
- Biosidus's estimated revenue per employee is $201,000
Employee Data
- Biosidus has 514 Employees.
- Biosidus grew their employee count by 10% last year.
Biosidus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Africa, Middle East & Euroasia | Reveal Email/Phone |
Biosidus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Biosidus?
Biosidus es una compañÃa de biotecnologÃa argentina que en las últimas dos décadas ha desarrollado un negocio global de investigación, desarrollo, producción y comercialización de biofármacos de alta calidad en territorios de Asia, Ãfrica, Europa del Este y América Latina. Biosidus cuenta con dos Plantas Industriales y un Laboratorio de Investigación y Desarrollo. La Planta Almagro, ubicada en la Ciudad Autónoma de Buenos Aires, está dedicada a actividades de I+D y a la producción de principios activos farmacéuticos, con capacidad productiva en fermentación bacteriana y cultivo celular masivo. Las operaciones de llenado aséptico, liofilización y empaque se llevan a cabo en la Planta Bernal, ubicada en dicha localidad de la Provincia de Buenos Aires.
keywords:N/A
N/A
Total Funding
514
Number of Employees
$103.3M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biosidus News
Roche; Biosidus; Nanogen; Amega Biotech; Zydus Cadila; 3sbio; Rhein Minapharm Biogenetics; PROBIOMED. Interferon Alpha-2a Biosimilar Market Breakdown by Type...
Roche; Biosidus; Zydus Cadila; Nanogen; Amega Biotech; Rhein Minapharm Biogenetics; PROBIOMED; 3Sbio. Interferon Sales Market Breakdown by Type:.
Biosidus; Zydus Cadila; Nanogen; Amega Biotech; Rhein Minapharm Biogenetics; PROBIOMED; 3sbio; Amgen; Bayer; Schering Plough; Merck. Interferon Biosimilar...